Johnson & Johnson Sees $1.2 Million Bearish Put Contract as Stock Hovers Near 52-Week Highs

By TrendSpider Editor

A single unusual put contract worth $1,224,000 in premium hit the tape for Johnson & Johnson on Tuesday, drawing attention to potential downside positioning as JNJ trades at $229.88. The contract targeted the $222.5 strike expiring June 18, 2026, with volume representing an extraordinary 22,500% of

Johnson & Johnson Sees $1.2 Million Bearish Put Contract as Stock Hovers Near 52-Week Highs

A single unusual put contract worth $1,224,000 in premium hit the tape for Johnson & Johnson on Tuesday, drawing attention to potential downside positioning as JNJ trades at $229.88. The contract targeted the $222.5 strike expiring June 18, 2026, with volume representing an extraordinary 22,500% of existing open interest. Against a 52-week range of $149.04 to $251.705, JNJ is currently trading in the upper half of its annual range, making this bearish activity worth watching closely.

Key Drivers of the JNJ Stock Move

The forward setup for JNJ is defined by this contract's tight expiration window. With less than 30 days until the June 18 expiry, whoever placed this trade is expecting a near-term catalyst or deterioration in price. JNJ has navigated significant headlines over the past year related to its pharmaceutical pipeline, litigation exposure, and broader healthcare sector headwinds. Any negative development in those areas between now and mid-June could serve as the trigger this options trader may be anticipating. The stock's proximity to the upper end of its 52-week range at $251.705 also means there is room for a pullback without breaking the longer-term trend, but a move below the $222.5 strike would represent a meaningful near-term breakdown.

JNJ Unusual Options Activity

One unusual options contract was flagged for Johnson & Johnson on Tuesday, May 19, 2026:

The total premium tied to this single contract came in at $1,224,000, making it the sole driver of today's unusual options flag. The out-of-the-money positioning combined with the massive volume-to-open-interest ratio points to a fresh, aggressive directional bet rather than routine hedging activity.

JNJ Seasonality

Late May and early June have historically been mixed for large-cap healthcare names, with volatility sometimes picking up ahead of major medical conferences and mid-year portfolio rebalancing. A June 18 expiration places this contract squarely within a window that could capture any catalysts from industry events or earnings-related guidance updates.

JNJ Relative Performance

JNJ edged higher by 0.39% on Tuesday, a modest gain that places it in line with typical defensive healthcare sector behavior during periods of broader market consolidation. Trading at $229.88, the stock sits meaningfully above its 52-week low of $149.04 but still has notable distance to its 52-week high of $251.705, leaving room for movement in either direction before reaching an extreme in its annual range.